201 related articles for article (PubMed ID: 319263)
1. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
Fuller RK; Khambatta PB; Gobezie GC
JAMA; 1977 Mar; 237(10):972-5. PubMed ID: 319263
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.
Santos J; Planas R; Pardo A; Durández R; Cabré E; Morillas RM; Granada ML; Jiménez JA; Quintero E; Gassull MA
J Hepatol; 2003 Aug; 39(2):187-92. PubMed ID: 12873814
[TBL] [Abstract][Full Text] [Related]
3. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
[TBL] [Abstract][Full Text] [Related]
4. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
Knauf H; Mutschler E
Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients.
Ljubicić N; Kujundzić M; Banić M; Vrkljan M
Scand J Gastroenterol; 1998 Apr; 33(4):441-7. PubMed ID: 9605268
[TBL] [Abstract][Full Text] [Related]
7. Comparison of six treatments of ascites in patients with liver cirrhosis. A clinical trial.
Descos L; Gauthier A; Levy VG; Michel H; Quinton A; Rueff B; Fermanian J; Fombonne E; Durbec JP
Hepatogastroenterology; 1983 Feb; 30(1):15-20. PubMed ID: 6339343
[TBL] [Abstract][Full Text] [Related]
8. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
[TBL] [Abstract][Full Text] [Related]
9. [Use of diuretics in the treatment of ascites in patients with cirrhosis].
Bourgeois N; Devaere S; Adler M; Cremer M
Acta Gastroenterol Belg; 1990; 53(2):256-60. PubMed ID: 2267905
[TBL] [Abstract][Full Text] [Related]
10. The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascites.
Heinrich F; Loew D; Dýcka J
Curr Med Res Opin; 1976-1977; 4(10):706-15. PubMed ID: 800972
[TBL] [Abstract][Full Text] [Related]
11. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
[TBL] [Abstract][Full Text] [Related]
12. Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
Fogel MR; Sawhney VK; Neal EA; Miller RG; Knauer CM; Gregory PB
J Clin Gastroenterol; 1981; 3 Suppl 1():73-80. PubMed ID: 7035545
[TBL] [Abstract][Full Text] [Related]
13. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
[TBL] [Abstract][Full Text] [Related]
14. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
Arroyo V; Ginès P; Planas R
Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of diuretics and paracentesis on lung function in patients with non-alcoholic cirrhosis and tense ascites.
Chang SC; Chang HI; Chen FJ; Shiao GM; Wang SS; Lee SD
J Hepatol; 1997 Apr; 26(4):833-8. PubMed ID: 9126796
[TBL] [Abstract][Full Text] [Related]
16. Medical treatment of ascites in cirrhosis.
Gerbes AL
J Hepatol; 1993; 17 Suppl 2():S4-9. PubMed ID: 8491970
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of ascites associated with cirrhosis.
Ginès P; Arrovo V; Rodés J
Drugs; 1992 Mar; 43(3):316-32. PubMed ID: 1374317
[TBL] [Abstract][Full Text] [Related]
18. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
Lennhoff M; Duhalt R; Peña JC
Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
[No Abstract] [Full Text] [Related]
20. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
Castagnolo B; De Colibus V; Napolitano L; Aliperta A; Caldarelli G; Abignente F
Clin Ter; 1977 Dec; 83(6):625-9. PubMed ID: 343976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
